Souad Moudallel

ORCID: 0000-0001-8130-9058
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Blood Pressure and Hypertension Studies
  • Medication Adherence and Compliance
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical studies and practices
  • Clinical practice guidelines implementation
  • Pharmacovigilance and Adverse Drug Reactions
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Arrhythmias and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Anesthesia and Sedative Agents
  • Pharmaceutical industry and healthcare
  • Cardiac electrophysiology and arrhythmias
  • Hemodynamic Monitoring and Therapy
  • Heparin-Induced Thrombocytopenia and Thrombosis

Vrije Universiteit Brussel
2018-2023

Universitair Ziekenhuis Brussel
2018-2023

Geneeskundige en Gezondheidsdienst
2018

Pharmac
2017

Background and Objectives: Appropriate dosing of direct oral anticoagulants (DOACs) is required to avoid under- overdosing that may precipitate strokes or thromboembolic events bleedings, respectively. Our objective was analyze the appropriateness DOAC according summaries product characteristics (SmPC). Furthermore, determinants for inappropriate prescribing were investigated. Methodology: Retrospective cohort study hospitalized patients aged ≥60 years with at least one intake during...

10.3389/fphar.2018.01220 article EN cc-by Frontiers in Pharmacology 2018-10-30

Objective This study aimed to assess implementation adherence (how well the patient’s actual intake matches prescribed dosing regimen) non-vitamin K antagonist oral anticoagulants (NOACs) and explore experiences with beliefs about NOACs in a real-world sample of long-term NOAC users. Methods A cross-sectional observational was conducted home-dwelling adults who started taking at least 1 year prior inclusion. Pharmacy dispensing data were used calculate Medication Possession Ratio (MPR)....

10.1136/heartjnl-2020-316781 article EN Heart 2020-06-23

To analyse the appropriateness of direct oral anticoagulant (DOAC) dosing and determinants for under-and overdosing as well acceptance implementation rates pharmacists' interventions.Cross-sectional study in a tertiary hospital hospitalized patients with atrial fibrillation on DOACs 2019 (n = 1688). Primary outcome was proportion inappropriate DOAC prescribing identification overdosing. Secondary outcomes included recommendations determination reasons...

10.1111/bcp.15017 article EN British Journal of Clinical Pharmacology 2021-07-31

Direct oral anticoagulants (DOACs) are increasingly used for stroke prevention in atrial fibrillation. However, little is known about the association between medication adherence, patient satisfaction and treatment knowledge. The objective was to determine patients' DOAC adherence their over time. Furthermore, we respectively investigated possible associations of knowledge relation adherence.Longitudinal study conducted fibrillation patients hospitalized 2019 a tertiary university hospital....

10.1111/bcp.15180 article EN British Journal of Clinical Pharmacology 2021-12-15

Aim: To analyze the appropriateness of DOAC dosing and determinants for under-and overdosing as well acceptance implementation rates interventions by clinical pharmacists. Methods: Cross-sectional study from January 2019-December 2019 in a tertiary hospital hospitalized patients with atrial fibrillation on DOACs (n=1688). Primary outcome was proportion inappropriate prescribing identification overdosing. Secondary outcomes included pharmacists’ advices determination reasons...

10.22541/au.161470725.55561763/v1 preprint EN Authorea (Authorea) 2021-03-02

<h3>Background</h3> The introduction of the direct oral anticoagulants (DOACs) widened options for anticoagulation in atrial fibrillation (AF) and venous thromboembolism. Although they have made more convenient, caution is warranted patients with renal impairment to decrease bleeding risk as are partly renally cleared. <h3>Purpose</h3> purpose this study was determine prescribing accuracy dabigatran etexilate, rivaroxaban apixaban according summaries product characteristics. Second,...

10.1136/ejhpharm-2018-eahpconf.368 article EN Section 5: Patient safety and quality assurance 2018-03-01

Abstract Background The emergence of non-vitamin K antagonist oral anticoagulants (NOAC) has caused a paradigm shift in anticoagulation therapy, with NOAC being increasingly used compared to vitamin antagonists. Despite the numerous RCTs NOAC, further follow-up on how this high risk new drug class is real-world clinical practice warranted. Purpose This study aimed describe use primary care sample long-term users, and investigated (i) adherence, (ii) patients' perceptions, (iii) interactions...

10.1093/eurheartj/ehz747.0112 article EN European Heart Journal 2019-10-01
Coming Soon ...